Accretion Pharmaceuticals Limited (NSE:ACCPL)
India
· Delayed Price · Currency is INR 68.65
+3.20 (4.89%)
At close: Mar 10, 2026
Accretion Pharmaceuticals Balance Sheet
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| Cash & Equivalents | 1.56 | 0.51 | 0.92 | 0.36 | 3.75 |
| Cash & Short-Term Investments | 1.56 | 0.51 | 0.92 | 0.36 | 3.75 |
| Cash Growth | - | -44.60% | 151.92% | -90.28% | - |
| Accounts Receivable | 218.48 | 116.61 | 58.05 | 57.99 | 40.68 |
| Other Receivables | - | 7.88 | 9.85 | - | - |
| Receivables | 241.62 | 124.86 | 68.58 | 57.99 | 40.68 |
| Inventory | 228.35 | 206.1 | 144.76 | 77.64 | 69.33 |
| Other Current Assets | 28.94 | 2.79 | 5.71 | 9.29 | 5.05 |
| Total Current Assets | 500.47 | 334.25 | 219.96 | 145.28 | 118.8 |
| Property, Plant & Equipment | 86.67 | 38.6 | 36.29 | 60.12 | 58.36 |
| Other Long-Term Assets | 2.4 | 25.14 | 18.14 | 0.39 | 0.26 |
| Total Assets | 590.75 | 398.74 | 274.39 | 205.8 | 177.41 |
| Accounts Payable | 22.63 | 18.39 | 16.4 | 78.5 | 67.37 |
| Accrued Expenses | - | 0.73 | 0.22 | 0.15 | 0.13 |
| Short-Term Debt | 71.11 | 93.9 | 41.56 | 37.4 | 22.26 |
| Current Portion of Long-Term Debt | - | 35.46 | 24.11 | 18.59 | 24.83 |
| Current Income Taxes Payable | - | 25.99 | 18.6 | 0.6 | 0.25 |
| Other Current Liabilities | 21.38 | 57.79 | 49.46 | 3.05 | 2.47 |
| Total Current Liabilities | 115.12 | 232.26 | 150.34 | 138.28 | 117.31 |
| Long-Term Debt | 7.45 | 11.68 | 69.11 | 28.67 | 28.99 |
| Pension & Post-Retirement Benefits | - | - | - | 0.44 | 0.34 |
| Long-Term Deferred Tax Liabilities | 2.4 | 1.95 | 0.01 | -0.02 | 0.02 |
| Other Long-Term Liabilities | - | - | - | - | 0 |
| Total Liabilities | 124.96 | 245.88 | 219.46 | 167.37 | 146.65 |
| Common Stock | 111.16 | 81.7 | 40 | 38.43 | 30.76 |
| Retained Earnings | 354.63 | 71.17 | 14.93 | - | - |
| Shareholders' Equity | 465.79 | 152.87 | 54.93 | 38.43 | 30.76 |
| Total Liabilities & Equity | 590.75 | 398.74 | 274.39 | 205.8 | 177.41 |
| Total Debt | 78.56 | 141.04 | 134.78 | 84.66 | 76.08 |
| Net Cash (Debt) | -77 | -140.53 | -133.86 | -84.29 | -72.33 |
| Net Cash Per Share | -8.33 | -17.53 | -17.61 | - | - |
| Filing Date Shares Outstanding | 10.31 | 8.17 | 8.17 | - | - |
| Total Common Shares Outstanding | 10.31 | 8.17 | 7.6 | - | - |
| Working Capital | 385.35 | 102 | 69.62 | 7 | 1.49 |
| Book Value Per Share | 45.18 | 18.71 | 7.23 | - | - |
| Tangible Book Value | 465.79 | 152.87 | 54.93 | 38.43 | 30.76 |
| Tangible Book Value Per Share | 45.18 | 18.71 | 7.23 | - | - |
| Land | - | 4.8 | 4.8 | 4.8 | 4.8 |
| Buildings | - | - | - | 21.02 | 20.12 |
| Machinery | - | 43.78 | 33.73 | 51.64 | 41.54 |
Source: S&P Capital IQ. Standard template. Financial Sources.